SCA
EXAS

Snowden Capital Advisors’s Exact Sciences EXAS Stock Holding History

Snowden Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,970
Closed -$200K – 1309
2025
Q4 		$200K Buy
+1,970
New +$158K 0.01% 1224
2023
Q3 		– Sell
-7,788
Closed -$731K – 1091
2023
Q2 		$731K Buy
7,788
+216
+3% +$16.9K 0.03% 566
2023
Q1 		$513K Sell
7,572
-137
-2% -$8.81K 0.02% 720
2022
Q4 		$382K Sell
7,709
-605
-7% -$24.7K 0.02% 834
2022
Q3 		$270K Buy
8,314
+1,332
+19% +$54.9K 0.01% 935
2022
Q2 		$275K Buy
6,982
+419
+6% +$22.4K 0.01% 904
2022
Q1 		$458K Buy
6,563
+6,023
+1,115% +$440K 0.02% 659
2021
Q4 		$42K Buy
+540
New +$47.7K ﹤0.01% 1085

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Snowden Capital Advisors's EXAS Position: Q1 2026 in Review

Snowden Capital Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,970 shares — an estimated $200K sold.

Snowden Capital Advisors first reported a position in EXAS in Q4 2021 and held it in 8 quarters. The position peaked at $731K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Snowden Capital Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Snowden Capital Advisors sold 1,970 Exact Sciences shares in Q1 2026, an estimated $200K.
  • Snowden Capital Advisors first reported a position in Exact Sciences in Q4 2021 and held it in 8 quarters.
  • Snowden Capital Advisors's Exact Sciences position peaked at $731K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.